Clinical Trial Update: Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intensified treatment with ACE inhibitors, AT1 receptor blockers, and statins for Alport Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Drugs mentioned

• ACE inhibitors
• AII receptor blockers (AT1 receptor blockers)
• Statins

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Alport Syndrome | Phase 2 | Status: COMPLETED